Home
Home

Regeneron

Regeneron drops 6% after Ophthotech reports positive data

Regeneron drops 6% after Ophthotech reports positive data
The Fly on the Wall

Has Regeneron Pharmaceuticals Become the Perfect Stock?

Has Regeneron Pharmaceuticals Become the Perfect Stock?
Motley Fool

Who’s on Biotech’s Endangered Species List? Mid-Sized Drugmakers

Who’s on Biotech’s Endangered Species List? Mid-Sized Drugmakers
Xconomy

Regeneron: FDA panel says no to Arcalyst for gout

Regeneron: FDA panel says no to Arcalyst for gout
Yahoo/AP

6 Best Biotech Stocks With More Upside Potential

6 Best Biotech Stocks With More Upside Potential
Seeking Alpha

Why These 2 Biotechs Are Soaring

Why These 2 Biotechs Are Soaring
Motley Fool

26 Drugs Facing FDA Approval in 2012

26 Drugs Facing FDA Approval in 2012
TheStreet.com

Pfizer, Gilead Sciences, Arena Pharmaceuticals Face Big Dates in May

Pfizer, Gilead Sciences, Arena Pharmaceuticals Face Big Dates in May
Minyanville

Seeing Black Gives Regeneron a 9% Pop

Seeing Black Gives Regeneron a 9% Pop
Motley Fool

Regeneron nearly doubles Eylea sales forecast

Regeneron nearly doubles Eylea sales forecast
Reuters